Crestline Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,681
Closed -$489K 497
2024
Q4
$489K Buy
+12,681
New +$489K 0.02% 542